ArticleJournal of pharmaceutical policy and practice2026
Reforming pharmacy education in Japan: insights from the 2022 model core curriculum in a global context.
Article in Journal of pharmaceutical policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A literature-informed Delphi framework for pediatric medication science books.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In response to demographic changes, technological innovation, and the increasing complexity of healthcare, Japan revised its Model Core Curriculum (MCC) for pharmacy education in 2022 (hereafter, the 2022 MCC). This reform aims to develop pharmacists with lifelong competencies, the ability to integrate emerging science and technology into practice, and strong interprofessional collaboration competencies. It represents a shift from traditional knowledge-based education to competency- and outcome-based education that addresses evolving societal needs in healthcare and pharmacy. This commentary outlines the key principles and evolution of the 2022 MCC. Faced with challenges such as population aging, declining birth rates, and healthcare system modernisation, Japanese pharmacy education is undergoing significant change. The 2022 MCC enhances practical clinical training, promotes community-oriented healthcare, and encourages scientific inquiry and problem-solving competencies among pharmacists. To support international collaboration and knowledge exchange, an English translation of the 2022 MCC Revised Edition has been published. As many countries face similar demographic and technological challenges, Japan's experience may provide useful insights to support the modernisation of pharmacy education globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.